Gillette India Ltd Q4 FY26 Results Analysis: PAT Jumps 21.3%, Grooming Margins Surge 780 bps

CompoundingAI Research Updated May 27, 2026 2 min read
Positive

Gillette India Ltd's Q4 FY26 numbers came in strong, with revenue of Rs. 792.00 Cr (+3.19% YoY) and PAT growth of +21.30% YoY. Here's a quick read of what worked, what to watch, and what management said.

Quick Details
Results dateMay 27, 2026
QuarterQ4 FY 2025-2026
Revenue (Q4)Rs. 792.00 Cr (+3.19% YoY)
PAT (Q4)Rs. 192.51 Cr (+21.30% YoY)
EBITDA margin35.00% (+560 bps YoY)
EPS (Q4)Rs. 59.08 (+21.30% YoY)
Market capRs. 25,421.49 Cr
CMPRs. 7,798.00

Quarter Snapshot

Gillette India delivered a profit-heavy quarter with PAT growing 21.3% YoY on just 3.2% revenue growth, as aggressive cost management and advertising efficiencies drove 560 bps of EBITDA margin expansion. Urban demand softness remains a key top-line headwind, but the company's ability to expand grooming segment margins by 780 bps demonstrates superior execution and pricing discipline.

Key Investment Insights

Key Positives

  • PAT grew 21.3% YoY to Rs.192.51 Cr in Q4 FY26 despite only 3.19% revenue growth.
  • EBITDA margin expanded 560 bps YoY to 35.0%, driven by advertising spend reduction of 21.2% YoY and depreciation decline of 23.0% YoY.
  • Grooming segment EBIT margin expanded 780 bps YoY to 35.2% despite just 1.35% revenue growth.
  • Oral Care segment grew 12.9% YoY with EBIT margin expanding 200 bps YoY to 20.6%.
  • CFO/PAT ratio of 0.93x for FY26 indicates quality of earnings.

Risk Factors

  • Revenue growth slowed to 3.2% YoY in Q4 from 15% in Q2, reflecting urban demand softness.
  • Cost of materials consumed surged 28.9% YoY, significantly outpacing revenue growth.
  • Net worth declined 7.5% as dividend payout of Rs.739.68 Cr exceeded FY26 PAT of Rs.654.31 Cr.
  • Cash balance declined by Rs.148.63 Cr due to dividend payout exceeding operating cash flow.
Share on X · LinkedIn · WhatsApp

Disclaimer: This results analysis is published for educational and informational purposes only. It is not investment advice, not a recommendation to buy, sell or hold any security.

Powered by CompoundingAI — AI research platform for Indian stocks, every claim cited from primary filings

Login Now